Investigating into the molecular interactions of flavonoids targeting NS2B-NS3 protease from ZIKA virus through in-silico approaches

References

• Aarthy, M., Kumar, D., Giri, R., & Singh, S. K. (2018). E7 oncoprotein of human papillomavirus: Structural dynamics and inhibitor screening study. Gene, 658, 159–177. doi:10.1016/j.gene.2018.03.026
   PubMed Web of Science ®Google Scholar
• Aguilera-Pesantes, D., & Miguel, A. M. (2017). Biochemical and Biophysical Research Communications Structure and sequence based functional annotation of Zika virus NS2b protein : Computational insights. Biochemical and Biophysical Research Communications, 492(4), 1–9. doi:10.1016/j.bbrc.2017.02.035
   Google Scholar
• Bachmetov, L., Shapira, A., Vorobeychik, M., Sathiyamoorthy, P., Benhar, I., & Molecular, R. Z. (2012). Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity. Journal of Viral Hepatitis, 19(2), 1–8. doi:10.1111/j.1365-2893.2011.01507.x
   Web of Science ®Google Scholar
• de Sousa, L. R. F., Wu, H., Nebo, L., Fernandes, J. B., da Silva, M. F. D G. F., Kiefer, W., … Vieira, P. C. (2015). Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: Inhibition kinetics and docking studies. Bioorganic & Medicinal Chemistry, 23(3), 466–470. doi:10.1016/j.bmc.2014.12.015
   PubMed Web of Science ®Google Scholar
• Ekins, S., & Rose, J. (2002). In silico ADME/Tox : The state of the art. Journal of Molecular Graphics and Modelling, 20, 305–309. doi:10.1016/S1093-3263(01)00127-9
   PubMedGoogle Scholar
• Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., … Shenkin, P. S. (2004). Glide : A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. Journal of Medicinal Chemistry, 47(7), 1739–1749. doi:10.1021/jm0306430
   PubMed Web of Science ®Google Scholar
• Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., … Mainz, D. T. (2006). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein − ligand complexes. Journal of Medicinal Chemistry, 49(21), 6177–6196. doi:10.1021/JM051256O
   PubMed Web of Science ®Google Scholar
• Frimayanti, N., Chee, C. F., Zain, S. M., & Rahman, N. A. (2011). Design of new competitive dengue Ns2b/Ns3 protease inhibitors-a computational approach. International Journal of Molecular Sciences, 12(2), 1089–1100. doi:10.3390/ijms12021089
   PubMed Web of Science ®Google Scholar
• Garcez, P. P., Loiola, E. C., Madeiro da Costa, R., Higa, L. M., Trindade, P., Delvecchio, R., … Rehen, S. K. (2016). Zika virus: Zika virus impairs growth in human neurospheres and brain organoids. Science, 352(6287), 816–818. doi:10.1126/science.aaf6116
   PubMed Web of Science ®Google Scholar
• Garg, N., Kumar, P., Gadhave, K., & Giri, R. (2019). The dark proteome of cancer: Intrinsic disorderedness and functionality of HIF-1α along with its interacting proteins. Progress in Molecular Biology and Translational Science, 166, 371–403. doi:10.1016/BS.PMBTS.2019.05.006
   PubMed Web of Science ®Google Scholar
• Gianni, S., Morrone, A., Giri, R., & Brunori, M. (2012). A folding-after-binding mechanism describes the recognition between the transactivation domain of c-Myb and the KIX domain of the CREB-binding protein. Biochemical and Biophysical Research Communications, 428(2), 205–209. doi:10.1016/j.bbrc.2012.09.112
   PubMed Web of Science ®Google Scholar
• Giri, R., Kumar, D., Sharma, N., & Uversky, V. N. (2016). Intrinsically disordered side of the zika virus proteome. Frontiers in Cellular and Infection Microbiology, 6, 144. doi:10.3389/fcimb.2016.00144
   PubMed Web of Science ®Google Scholar
• Giri, R., Morrone, A., Toto, A., Brunori, M., & Gianni, S. (2013). Structure of the transition state for the binding of c-Myb and KIX highlights an unexpected order for a disordered system. Proceedings of the National Academy of Sciences of Sciences, 110(37), 14942–14947. doi:10.1073/pnas.1307337110
   PubMed Web of Science ®Google Scholar
• Gupta, S., Suryanarayanan, V., Yadav, S., Singh, S. K., & Saxena, J. K. (2017). Delineating the role of ionic interactions in structural and functional integrity of B. malayi Guanylate kinase. International Journal of Biological Macromolecules, 98, 357–365. doi:10.1016/j.ijbiomac.2017.01.098
   PubMed Web of Science ®Google Scholar
• Hunkapiller, M. W., Forgac, M. D., & Richards, J. H. (1976). Mechanism of action of serine proteases: Tetrahedral intermediate and concerted proton transfer. Biochemistry, 15(25), 5581–5588. doi:10.1021/bi00670a024
   PubMed Web of Science ®Google Scholar
• Ioakimidis, L., Thoukydidis, L., Mirza, A., Naeem, S., & Reynisson, J. (2008). Benchmarking the reliability of QikProp. Correlation between experimental and predicted values. QSAR & Combinatorial Science, 27(4), 445–456. doi:10.1002/qsar.200730051
   Google Scholar
• Joshi, P., & Vendruscolo, M. (2015). Druggability of intrinsically disordered proteins. Advances in Experimental Medicine and Biology, 870, 383–400. doi:10.1007/978-3-319-20164-1_13..
   PubMed Web of Science ®Google Scholar
• Katzenmeier, G. (2004). Inhibition of the NS2B-NS3 protease—Towards a causative therapy for dengue virus diseases. Dengue Bulletin, 28(4), 58–67.
   Google Scholar
• Kim, K., Kim, K. H., Kim, H. Y., Cho, H. K., Sakamoto, N., & Cheong, J. (2010). Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway. FEBS Letters, 584(4), 707–712. doi:10.1016/j.febslet.2009.12.019
   PubMed Web of Science ®Google Scholar
• Kim, Y., Narayanan, S., & Chang, K. O. (2010). Inhibition of influenza virus replication by plant-derived isoquercetin. Antiviral Research, 88(2), 227–235. doi:10.1016/j.antiviral.2010.08.016
   PubMed Web of Science ®Google Scholar
• Klinski, E., Semov, A., Yan, X., Alakhov, V., Muyzhnek, E., & Kiselev, V. (2013). Block copolymer based composition of epigallocatechin-3-gallate with improved oral bioavailability as a way to increase its therapeutic activity. Journal of Nanomedicine & Biotherapeutic Discovery, 3(2), 3–7. doi:10.4172/2155-983X.100011
   Google Scholar
• Kumar, A., Liang, B., Aarthy, M., Singh, S. K., Garg, N., Mysorekar, I. U., & Giri, R. (2018). Hydroxychloroquine inhibits zika virus NS2B-NS3 protease. ACS Omega, 3(12), 18132–18141. doi:10.1021/acsomega.8b01002
   PubMed Web of Science ®Google Scholar
• Kumar, D., Aarthy, M., Kumar, P., Singh, S. K., Uversky, V. N., & Giri, R. (2019). Targeting the NTPase site of Zika virus NS3 helicase for inhibitor discovery. Journal of Biomolecular Structure and Dynamics, 1–16. doi:10.1080/07391102.2019.1689851
   PubMed Web of Science ®Google Scholar
• Kumar, D., Sharma, N., & Giri, R. (2017). Therapeutic interventions of cancers using intrinsically disordered proteins as drug targets: C -Myc as model system. Cancer Informatics, 16, 1–7. doi:10.1177/1176935117699408
   PubMed Web of Science ®Google Scholar
• Kumar, D., Singh, A., Kumar, P., Uversky, V. N., Rao, C. D., & Giri, R. (2019). Understanding the penetrance of intrinsic protein disorder in rotavirus proteome. International Journal of Biological Macromolecules. doi:10.1016/j.ijbiomac.2019.09.166
   Web of Science ®Google Scholar
• Kumar, P., Kumar, D., & Giri, R. (2019). Targeting the nsp2 cysteine protease of chikungunya virus using FDA approved library and selected cysteine protease inhibitors. Pathogens, 8(3), 128. doi:10.3390/pathogens8030128
   PubMed Web of Science ®Google Scholar
• Kumar, P., Saumya, K. U., & Giri, R. (2019). Identification of peptidomimetic compounds as potential inhibitors against MurA enzyme of Mycobacterium tuberculosis. Journal of Biomolecular Structure and Dynamics, 1–21. doi:10.1080/07391102.2019.1696231
   PubMed Web of Science ®Google Scholar
• Lambert, J. D., Sang, S., Hong, J., Kwon, S. J., Lee, M. J., Ho, C. T., & Yang, C. S. (2006). Peracetylation as a means of enhancing in vitro bioactivity and bioavailability of epigallocatechin-3-gallate. Drug Metabolism and Disposition, 34(12), 2111–2116. doi:10.1124/dmd.106.011460
   PubMed Web of Science ®Google Scholar
• Lei, J., Hansen, G., Nitsche, C., Klein, C. D., Zhang, L., & Hilgenfeld, R. (2016). Crystal structure of Zika virus NS2B-NS3 protease in complex with a boronate inhibitor. Science, 353(6298), 503–505. doi:10.1126/science.aag2419
   PubMed Web of Science ®Google Scholar
• Lim, H. J., Nguyen, T. T. H., Kim, N. M., Park, J. S., Jang, T. S., & Kim, D. (2017). Inhibitory effect of flavonoids against NS2B-NS3 protease of ZIKA virus and their structure activity relationship. Biotechnology Letters, 39(3), 415–421. doi:10.1007/s10529-016-2261-6
   PubMed Web of Science ®Google Scholar
• Lo, K., Knox, J. E., Phong, W. Y., Ma, N. L., Yin, Z., Sampath, A., … Keller, T. H. (2007). Communication Yellow fever virus NS3 protease : Peptide-inhibition studies. Journal of General Virology, 88(8), 2223–2227. doi:10.1099/vir.0.82735-0
   PubMedGoogle Scholar
• Löhr, K., Knox, J. E., Phong, W. Y., Ma, N. L., Yin, Z., Sampath, A., … Keller, T. H. (2007). Yellow fever virus NS3 protease: Peptide-inhibition studies. Journal of General Virology, 88(8), 2223–2227. doi:10.1099/vir.0.82735-0
   PubMedGoogle Scholar
• Lyu, S.-Y., Rhim, J.-Y., & Park, W.-B. (2005). Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro. Archives of Pharmacal Research, 28(11), 1293–1301. doi:10.1024/0301-1526.34.4.281a
   PubMed Web of Science ®Google Scholar
• Madhavi Sastry, G., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013). Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. Journal of Computer-Aided Molecular Design, 27(3), 221–234. doi:10.1007/s10822-013-9644-8
   PubMed Web of Science ®Google Scholar
• Mereles, D., & Hunstein, W. (2011). Epigallocatechin-3-gallate (EGCG) for clinical trials: More pitfalls than promises? International Journal of Molecular Sciences, 12(9), 5592–5603. doi:10.3390/ijms12095592
   PubMed Web of Science ®Google Scholar
• Mishra, P. M., Uversky, V. N., & Giri, R. (2018). Molecular recognition features in zika virus proteome. Journal of Molecular Biology, 430(16), 2372–2388. doi:10.1016/j.jmb.2017.10.018
   PubMed Web of Science ®Google Scholar
• Mobley, D. L., & Dill, K. A. (2009). Binding of small-molecule ligands to proteins: “What you see” is not always “what you get”. Structure, 17(4), 489–498. doi:10.1016/j.str.2009.02.010
   PubMed Web of Science ®Google Scholar
• Mottin, M., Borba, J. V. V. B., Braga, R. C., Torres, P. H. M., Martini, M. C., Proenca-Modena, J. L., … Horta Andrade, C. (2018). The A–Z of Zika drug discovery. Drug Discovery Today, 23(11), 1833–1847. doi:10.1016/j.drudis.2018.06.014
   PubMed Web of Science ®Google Scholar
• Mounce, B. C., Cesaro, T., Carrau, L., Vallet, T., & Vignuzzi, M. (2017). Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding. Antiviral Research, 142, 148–157. doi:10.1016/j.antiviral.2017.03.014
   PubMed Web of Science ®Google Scholar
• Mulakala, C., & Viswanadhan, V. N. (2013). Could MM-GBSA be accurate enough for calculation of absolute protein/ligand binding free energies? Journal of Molecular Graphics and Modelling, 46, 41–51. doi:10.1016/j.jmgm.2013.09.005
   PubMed Web of Science ®Google Scholar
• Nutho, B., Mulholland, A. J., & Rungrotmongkol, T. (2019). The reaction mechanism of Zika virus NS2B/NS3 serine protease inhibition by dipeptidyl aldehyde: A QM/MM study. Physical Chemistry Chemical Physics, 21(27), 14945–14956. doi:10.1039/C9CP02377A
   PubMed Web of Science ®Google Scholar
• Pérez-Pérez, M.-J., Delang, L., Ng, L. F. P., & Priego, E.-M. (2019). Chikungunya virus drug discovery: Still a long way to go? Expert Opinion on Drug Discovery, 14(9), 1–12. doi:10.1080/17460441.2019.1629413
   PubMed Web of Science ®Google Scholar
• Raza, S., Abbas, G., & Azam, S. S. (2019). Screening pipeline for Flavivirus based inhibitors for Zika virus NS1. IEEE/ACM Transactions on Computational Biology and Bioinformatics, 1–1. doi:10.1109/tcbb.2019.2911081
   Web of Science ®Google Scholar
• Rimmert, B., Sabet, S., Ackad, E., & Yousef, M. S. (2014). A 3D structural model and dynamics of hepatitis C virus NS3/4A protease (genotype 4a, strain ED43) suggest conformational instability of the catalytic triad : Implications in catalysis and drug resistivity. Journal of Biomolecular Structure and Dynamics, 32(6), 950–958. doi:10.1080/07391102.2013.800001
   PubMed Web of Science ®Google Scholar
• Roy, A., Lim, L., Srivastava, S., Lu, Y., & Song, J. (2017). Solution conformations of Zika NS2B-NS3pro and its inhibition by natural products from edible plants. PLoS One, 12(7), e0180632. doi:10.1371/journal.pone.0180632
   PubMed Web of Science ®Google Scholar
• Saiz, J.-C., & Martín-Acebes, M. A. (2017). The race to find antivirals for zika virus. Antimicrobial Agents and Chemotherapy, 61(6), e00411–e00417. doi:10.1128/AAC.00411-17
   PubMed Web of Science ®Google Scholar
• Samanta, P. N., & Das, K. K. (2017). Journal of molecular graphics and modelling inhibition activities of catechol diether based non-nucleoside inhibitors against the HIV reverse transcriptase variants : Insights from molecular docking and ONIOM calculations. Journal of Molecular Graphics and Modelling, 75, 294–305. doi:10.1016/j.jmgm.2017.06.011
   PubMed Web of Science ®Google Scholar
• Seniya, C., Mishra, H., Yadav, A., Sagar, N., Chaturvedi, B., Uchadia, K., & Wadhwa, G. (2013). Antiviral potential of 4-hydroxypanduratin A, secondary metabolite of Fingerroot, Boesenbergia pandurata (Schult.), towards Japanese Encephalitis virus NS2B/NS3 protease. Bioinformation, 9(1), 54–60. doi:10.6026/97320630009054
   PubMedGoogle Scholar
• Senthilvel, P., Lavanya, P., Kumar, K. M., Swetha, R., Anitha, P., Bag, S., Sarveswari, S., & Anbarasu, A. (2013). Flavonoid from Carica papaya inhibits NS2B-NS3 protease and prevents Dengue 2 viral assembly. Bioinformation, 9(18), 889–895. doi:10.6026/97320630009889
   PubMedGoogle Scholar
• Sharma, N., Murali, A., Singh, S. K., & Giri, R. (2017). Epigallocatechin gallate, an active green tea compound inhibits the Zika virus entry into host cells via binding the envelope protein. International Journal of Biological Macromolecules, 104, 1046–1054. doi:10.1016/j.ijbiomac.2017.06.105
   PubMed Web of Science ®Google Scholar
• Sherman, W., Day, T., Jacobson, M. P., Friesner, R. A., & Farid, R. (2006). Novel procedure for modeling ligand/receptor induced fit effects. Journal of Medicinal Chemistry, 49(2), 534–553. doi:10.1021/jm050540c
   PubMed Web of Science ®Google Scholar
• Singh, A., Kumar, A., Uversky, V. N., & Giri, R. (2018). Understanding the interactability of chikungunya virus proteins via molecular recognition feature analysis. RSC Advances, 8(48), 27293–27303. doi:10.1039/C8RA04760J
   PubMed Web of Science ®Google Scholar
• Singh, A., Kumar, A., Yadav, R., Uversky, V. N., & Giri, R. (2018). Deciphering the dark proteome of Chikungunya virus. Scientific Reports, 8(1), 5822. doi:10.1038/s41598-018-23969-0
   PubMed Web of Science ®Google Scholar
• Toto, A., Camilloni, C., Giri, R., Brunori, M., Vendruscolo, M., & Gianni, S. (2016). Molecular recognition by templated folding of an intrinsically disordered protein. Scientific Reports, 6(1), 21994. doi:10.1038/srep21994
   PubMedGoogle Scholar
• Toto, A., Giri, R., Brunori, M., & Gianni, S. (2014). The mechanism of binding of the KIX domain to the mixed lineage leukemia protein and its allosteric role in the recognition of c-Myb. Protein Science, 23(7), 962–969. doi:10.1002/pro.2480
   PubMed Web of Science ®Google Scholar
• Uversky, V. N. (2012). Intrinsically disordered proteins and novel strategies for drug discovery. Expert Opinion on Drug Discovery, 7(6), 475–488. doi:10.1517/17460441.2012.686489
   PubMed Web of Science ®Google Scholar
• Zhang, C., Li, H., Jiang, W., Zhang, X., & Li, G. (2016). Icaritin inhibits the expression of alpha-fetoprotein in hepatitis B virus-infected hepatoma cell lines through post-transcriptional regulation. Oncotarget, 7(50), 83755–83766. doi:10.18632/oncotarget.13194
   PubMedGoogle Scholar
• Zhou, H., Singh, N. J., & Kim, K. S. (2006). Homology modeling and molecular dynamics study of West Nile virus NS3 protease: A molecular basis for the catalytic activity increased by the NS2B cofactor. Proteins: Structure, Function, and Bioinformatics, 65(3), 692–701. doi:10.1002/prot.21129
   PubMed Web of Science ®Google Scholar